中国医药: 关于子公司原料药获得CEP证书的公告

Group 1 - The company announced that its subsidiary, Tianfang Pharmaceutical Co., Ltd., has received the CEP certificate for Clindamycin Phosphate from the European Directorate for the Quality of Medicines (EDQM) [1][2] - The CEP certificate indicates that the product is qualified to enter the European market and other markets that recognize the CEP certificate, enhancing the company's international business prospects and global market competitiveness [2] Group 2 - As of the announcement date, there are 14 approved CEP certificates for Clindamycin Phosphate globally, with 9 being valid and 5 invalid [2] - The company plans to actively promote the production and sales of Clindamycin Phosphate, although future sales may be affected by industry policies and market conditions [2]